相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Early effects of parathyroid hormone on vascularized bone regeneration and implant osseointegration in aged rats
Liting Jiang et al.
BIOMATERIALS (2018)
Glucocorticoids, Inflammation and Bone
Melek Guler-Yuksel et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Lack of endogenous parathyroid hormone delays fracture healing by inhibiting vascular endothelial growth factor-mediated angiogenesis
Qingfeng Ding et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
Kenneth G. Saag et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis
Geetha Mohan et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
ARTHRITIS CARE & RESEARCH (2017)
Osteocyte Mechanobiology
Yuhei Uda et al.
CURRENT OSTEOPOROSIS REPORTS (2017)
Glucocorticoids and osteocyte autophagy
Wei Yao et al.
BONE (2013)
Glucocorticoid-Induced Osteoporosis and Osteonecrosis
Robert S. Weinstein
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Glucocorticoid dose determines osteocyte cell fate
Junjing Jia et al.
FASEB JOURNAL (2011)
Guidance for the adjustment of FRAX according to the dose of glucocorticoids
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice
Robert S. Weinstein et al.
AGING CELL (2010)
Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity
Robert S. Weinstein
BONE (2010)
Glucocorticoid-Induced Autophagy in Osteocytes
Xuechun Xia et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
A Mouse Model for Glucocorticoid-Induced Osteonecrosis: Effect of a Steroid Holiday
Lei Yang et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2009)
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
David M. Reid et al.
LANCET (2009)
Glucocorticoid-Induced Bone Loss in Mice Can Be Reversed by the Actions of Parathyroid Hormone and Risedronate on Different Pathways for Bone Formation and Mineralization
Wei Yao et al.
ARTHRITIS AND RHEUMATISM (2008)
Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis - A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice
Wei Yao et al.
ARTHRITIS AND RHEUMATISM (2008)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice
NE Lane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
The influence of water removal on the strength and toughness of cortical bone
JS Nyman et al.
JOURNAL OF BIOMECHANICS (2006)
Oral glucocorticoid use is associated with an increased risk of fracture
M Steinbuch et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy
TP Van Staa et al.
ARTHRITIS AND RHEUMATISM (2003)
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy
S Wallach et al.
CALCIFIED TISSUE INTERNATIONAL (2000)